Sun Pharmaceutical Industries has recorded a 5 percent on-year growth in consolidated profit of Rs 2,166 crore for the quarter ended December 31, 2022, as against Rs 2,059 crore a year back. Net profit was down 4 percent against Rs 2,262 crore reported in the September quarter.